Merck Research and Development Expenses 2010-2024 | MRK

Merck research and development expenses for the twelve months ending December 31, 2024 were $17.938B, a 41.25% decline year-over-year.

  • Merck annual research and development expenses for 2024 were $17.938B, a 41.25% decline from 2023.
  • Merck annual research and development expenses for 2023 were $30.531B, a 125.35% increase from 2022.
  • Merck annual research and development expenses for 2022 were $13.548B, a 10.64% increase from 2021.

Merck Research and Development Expenses 2010-2024 | MRK

  • Merck annual research and development expenses for 2024 were $17.938B, a 41.25% decline from 2023.
  • Merck annual research and development expenses for 2023 were $30.531B, a 125.35% increase from 2022.
  • Merck annual research and development expenses for 2022 were $13.548B, a 10.64% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$823.1B
Johnson & Johnson (JNJ)$380.1B
Novo Nordisk (NVO)$374.3B
AbbVie (ABBV)$348.4B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Pfizer (PFE)$146.7B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B